In the end, Sony Corp.'s alliance in the medical equipment business with scandal-tainted Olympus Corp. will help the loss-making electronics giant, it's just a matter of giving it enough time, analysts say.
The two companies will set up a joint venture by yearend to develop endoscopes, focusing on a type used in keyhole surgery, they said in a statement. Sony will hold 51 percent of that venture and Olympus 49 percent.
Sony will also invest ¥50 billion in Olympus, making it its single biggest shareholder, with slightly more than 11 percent of its outstanding shares.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.